Universal antiviral therapy shows promise in animals.
New antiviral therapy inspired by rare mutation prevents viral replication in animals.
Why it matters
- Potential game-changer in fighting viral diseases.
- Inspired by a rare mutation that provides broad antiviral protection.
- Could be crucial for pandemic preparedness.
By the numbers
- Few dozen people have the rare mutation.
- Prevents influenza and SARS-CoV-2 replication in animals.
- Protection lasts ~3-4 days.
The big picture
- Therapy mimics rare mutation’s antiviral effects via mRNA technology.
- Could offer broad protection against various viruses.
What they're saying
- Skepticism about the claim.
- Peer-reviewed study link shared.
Caveats
- Still in animal testing.
- Delivery methods need improvement.
- Duration of protection is limited.
What’s next
- Optimize drug delivery.
- Human trials and longer protection duration studies.